{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:58:07Z","timestamp":1769216287794,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012834","name":"Gifu University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012834","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>MicroRNA(miR)-143 and miR-145 are mainly expressed in vascular smooth muscle cells. However, the relationship between plasma miR-143 or miR-145 levels and the left ventricular (LV) function in patients with heart diseases remains unclear. Blood samples were taken from the antecubital vein in patients with heart diseases (<jats:italic>n<\/jats:italic>\u2009=\u200952), such as coronary artery disease, old myocardial infarction, cardiomyopathy, and valvular heart disease, and controls without heart diseases (<jats:italic>n<\/jats:italic>\u2009=\u200922). We measured plasma miR-143 and -145 levels by quantitative RT\u2013PCR using TaqMan MicroRNA Assays and THUNDERBIRD Probe qPCR Mix. Plasma BNP levels were also measured. Echocardiography was performed to measure the LV ejection fraction (LVEF) and LV dilation. Plasma miR-143 and miR-145 levels were significantly higher in patients with heart diseases than in controls, respectively. Plasma miR-143 and miR-145 levels were significantly higher in patients with LVEF\u2009&lt;\u200950% than in those with LVEF \u2267 50%, respectively. Plasma miR-143 and miR-145 levels were inversely correlated with LVEF, respectively. Plasma miR-143 and miR-145 levels were positively correlated with LV end-systolic dimension, respectively. Plasma miR-143 and -145 levels were positively correlated with plasma BNP levels, respectively. Plasma BNP levels were inversely correlated with LVEF. Plasma miR-143 and miR-145 levels are elevated in patients with LV dysfunction and may counteract LV dysfunction.<\/jats:p>","DOI":"10.1007\/s00380-024-02410-9","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T07:01:47Z","timestamp":1715151707000},"page":"867-876","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Plasma microRNA-143 and microRNA-145 levels are elevated in patients with left ventricular dysfunction"],"prefix":"10.1007","volume":"39","author":[{"given":"Hirotaka","family":"Murase","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Minatoguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Heishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Satake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Yoshizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisaaki","family":"Komaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Ojio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Akao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Minatoguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Okura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,8]]},"reference":[{"key":"2410_CR1","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/ejhf.319","volume":"17","author":"H Shimokawa","year":"2015","unstructured":"Shimokawa H, Miura M, Nochioka K, Sakata Y (2015) Heart failure as a general pandemic in Asia. Eur J Heart Fail 17:884\u2013892","journal-title":"Eur J Heart Fail"},{"key":"2410_CR2","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/S0735-1097(01)01116-0","volume":"37","author":"T Tsutamoto","year":"2001","unstructured":"Tsutamoto T, Wada A, Maeda K (2001) Effects of spilonolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure. J Am Coll Cardiol 37:1228\u20131233","journal-title":"J Am Coll Cardiol"},{"key":"2410_CR3","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1053\/euhj.1999.1746","volume":"20","author":"T Tsutamoto","year":"1999","unstructured":"Tsutamoto T, Wada A, Maeda K, Hisanaga T, Mabuchi N, Hayashi M, Ohnishi M, Sawaki M, Fujii M, Horie H, Sugimoto Y, Kinoshita M (1999) Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Eur Heart J 20:1799\u20131807","journal-title":"Eur Heart J"},{"key":"2410_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281\u2013297","journal-title":"Cell"},{"key":"2410_CR5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros V (2004) The functions of animal microRNAs. Nature 431:350\u2013355","journal-title":"Nature"},{"key":"2410_CR6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00380-022-02231-8","volume":"38","author":"Y Zou","year":"2023","unstructured":"Zou Y, Yin J, Zhang Q (2023) MIR-568 mitigated cardiomyocytes apoptosis, oxidative stress response and cardiac dysfunction via targeting SMURF2 in heart failure rats. Heart Vessels 38:857\u2013868","journal-title":"Heart Vessels"},{"key":"2410_CR7","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s00380-018-01336-3","volume":"34","author":"W Yang","year":"2019","unstructured":"Yang W, Han Y, Yang C, Chen Y, Zhao W, Su X, Yang K, Jin W (2019) MicroRNA-19b-1 reverses ischaemia-induced heart failure by inhibiting cardiomyocyte apoptosis and targeting Bcl2 I11\/BIM. Heart Vessels 34:1221\u20131229","journal-title":"Heart Vessels"},{"key":"2410_CR8","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nature08195","volume":"460","author":"KR Cordes","year":"2009","unstructured":"Cordes KR, Sheehy NT, White M, Berry E, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D (2009) miR-145 and miR-143 regulate smooth muscle cell fate decisions. Nature 460:705\u2013710","journal-title":"Nature"},{"key":"2410_CR9","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1160\/TH13-11-0905","volume":"112","author":"F Sala","year":"2014","unstructured":"Sala F, Aranda JF, Rotllan N, Ram\u00edrez CM, Aryal B, Elia L, Condrelli G, Catapano AL, Fernandez-Hernando C, Norata GD (2014) MiR-143\/145 deficiency attenuates the progression of atherosclerosis in Ldlr-\/-mice. Thromb Haemost 112:796\u2013802","journal-title":"Thromb Haemost"},{"key":"2410_CR10","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1242\/dev.050526","volume":"137","author":"DC Deacon","year":"2010","unstructured":"Deacon DC, Nevis KR, Cashman TJ, Xhou Y, Zhao L, Washko D, Guner-Ataman B, Burns CG, Burns CE (2010) The miR-143-adducin3 pathway is essential for cardiac chamber morphogenesis. Development 137:1887\u20131896","journal-title":"Development"},{"key":"2410_CR11","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/j.febslet.2013.04.018","volume":"587","author":"R Li","year":"2013","unstructured":"Li R, Yan G, Zhang Q, Jiang Y, Sun H, Hu Y, Sun J, Xu B (2013) miR-145 inhibits isoproterenol-induced cardiomyocyte hypertrophy by targeting the expression and localization of GATA 6. FEBS Lett 587:1754\u20131761","journal-title":"FEBS Lett"},{"key":"2410_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/531740","volume":"2015","author":"W Zhao","year":"2015","unstructured":"Zhao W, Zhao SP, Zhao YH (2015) MicroRNA-143\/-145 in cardiovascular diseases. Biomed Res Int 2015:531740","journal-title":"Biomed Res Int"},{"key":"2410_CR13","doi-asserted-by":"publisher","first-page":"H1813","DOI":"10.1152\/ajpheart.00709.2014","volume":"309","author":"K Higashi","year":"2015","unstructured":"Higashi K, Yamada Y, Minatoguchi S, Baba S, Iwasa M, Kanamori H, Kawasaki M, Nishigaki K, Takemura G, Kumazaki M, Akao Y, Minatoguchi S (2015) MicroRNA-145 repairs infarcted myocardium by accelerating cardiomyocyte. Autophagy. Am J Physiol Heart Circ Physiol 309:H1813\u2013H1826","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2410_CR14","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1253\/circj.CJ-22-0698","volume":"87","author":"A Satake","year":"2023","unstructured":"Satake A, Minatoguchi S, Heishima K, Yasuda S, Murase H, Yoshizumi R, Komaki M, Baba S, Ojio S, Tanaka T, Akao Y, Minatoguchi S, Okura H (2023) An increase in plasma micro RNA-143 in the acute phase is positively correlated with recovery of cardiac function in the chronic phase in patients with acute myocardial infarction. Circ J 87:824\u2013833","journal-title":"Circ J"},{"key":"2410_CR15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1476-4598-9-136","volume":"9","author":"Y Akao","year":"2010","unstructured":"Akao Y, Naoe T, Hirata I, Nakagawa Y, Iio A (2010) Identification of non-coding RNAs embracing microRNA-143\/145 cluster. Mol Cancer 9:136","journal-title":"Mol Cancer"},{"key":"2410_CR16","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1111\/cas.15065","volume":"112","author":"M Fukada","year":"2021","unstructured":"Fukada M, Matsuhashi N, Takahashi T, Sugito N, Heishima K, Yoshida K, Akao Y (2021) Postoperative changes in plasma miR21-5p as a novel biomarker for colorectal cancer recurrence: a prospective study. Cancer Sci 112:4270\u20134280","journal-title":"Cancer Sci"},{"key":"2410_CR17","doi-asserted-by":"publisher","first-page":"25377","DOI":"10.3390\/ijms161025377","volume":"16","author":"K Heishima","year":"2015","unstructured":"Heishima K, Mori T, Ichikawa Y, Sakai H, Kuranaga Y, Nakagawa T, Tanaka Y, Okamura Y, Masuzawa M, Sugito N, Murakami M, Yamada N, Akao Y, Maruo K (2015) MicroRNA-214 and microRNA-126 are potential biomarkers for malignant endothelial proliferative diseases. Int J Mol Sci 16:25377\u201325391","journal-title":"Int J Mol Sci"},{"key":"2410_CR18","first-page":"3485","volume":"21","author":"AV Zhelankin","year":"2020","unstructured":"Zhelankin AV, Vasiliev SV, Stonogina DA, Babalyan KA, Sharova EI, Doludin YV, Shchekochikhin DY, Generozov EV, Akselrod AS (2020) Elevated plasma levels of circulating extracellular miR-320a-3p in patients with paroxysmal atrial fibrillation. Int J Med Sci 21:3485","journal-title":"Int J Med Sci"},{"key":"2410_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250072","volume":"16","author":"T Yamano","year":"2021","unstructured":"Yamano T, Kubo S, Sonoda E, Kominato T, Kimura K, Yasuhara M, Kataoka K, Son J, Babaya A, Takenaka Y, Matsubara T, Beppu N, Ikeda M (2021) Assessment of circulating microRNA specific for patients with familial adenomatous polyposis. PLoS ONE 16:e0250072","journal-title":"PLoS ONE"},{"key":"2410_CR20","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1172\/JCI38864","volume":"119","author":"T Boettger","year":"2009","unstructured":"Boettger T, Beetz N, Kostin S, Schneider J, Kruger M, Hein L, Braun T (2009) Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143\/145 gene cluster. J Clin Invest 119:2634\u20132647","journal-title":"J Clin Invest"},{"key":"2410_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1177\/039463201202500216","volume":"25","author":"GD Norata","year":"2012","unstructured":"Norata GD, Pinna C, Zappella F, Elia L, Sala A (2012) Condorelli G\u3001Catapano AL (2012) MicroRNA 143\u2013145 deficiency impairs vascular function. Int J Immunopathol Pharmacol 25:467\u2013474","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2410_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/ncb2441","volume":"14","author":"E Hergenreider","year":"2012","unstructured":"Hergenreider E, Heydt S, Treguer K, Boettger T, Horrevoets AJG, Zeiher AM, Scheffer MP, Frangakis AS, Yin X, Mayr M, Braun T, Urbich C, Boon RA (2012) Dimmeler S (2012) Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 14:249\u2013256","journal-title":"Nat Cell Biol"},{"key":"2410_CR23","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1172\/JCI38864","volume":"119","author":"T Boettger","year":"2009","unstructured":"Boettger T, Beetz N, Kostin S, Schneider J, Kruger M, Hein L, Braun T (2009) Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143\/145 gene cluster. J Clin Invest 119:2634\u20132647","journal-title":"J Clin Invest"},{"key":"2410_CR24","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCRESAHA.109.215566","volume":"107","author":"S Fichtcherer","year":"2010","unstructured":"Fichtcherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, R\u00f6xe T, M\u00fcller-Ardogan M, Bonauer A, Zeiher AM, Dimmeler S (2010) Circulating microRNAs in patients with coronary artery disease. Circ Res 107:677\u2013684","journal-title":"Circ Res"},{"key":"2410_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1517\/14728222.2013.745512","volume":"17","author":"D Santovito","year":"2013","unstructured":"Santovito D, Mandolini C, Marcantonio P, De Nardis V, Bucci M, Paganelli C, Magnacca F, Ucchino S, Mastroiacovo D, Desideri G, Mezzetti A, Cipollone F (2013) Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients. Expert Opin Ther Targets 17:217\u2013223","journal-title":"Expert Opin Ther Targets"},{"key":"2410_CR26","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1038\/cdd.2009.153","volume":"16","author":"L Elia","year":"2009","unstructured":"Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MVG, Peterson KL, Indolfi C, Catalucci D, Chen J, Courtneidge SA, Condorelli G (2009) The knockout of miR-143 and -145 alters smooth muscle muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 16:1590\u20131598","journal-title":"Cell Death Differ"},{"key":"2410_CR27","doi-asserted-by":"publisher","first-page":"24213","DOI":"10.1073\/pnas.2008323117","volume":"117","author":"H Geekiyanagea","year":"2020","unstructured":"Geekiyanagea H, Rayatpishehb S, Wohlschlegelb JA, Brown Jrc R, Ambrosa V (2020) Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides. Proc Natl Acad Sci USA 117:24213\u201324223","journal-title":"Proc Natl Acad Sci USA"},{"key":"2410_CR28","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1093\/cvr\/cvx118","volume":"113","author":"TM Ribeiro-Rodrigues","year":"2017","unstructured":"Ribeiro-Rodrigues TM, Laundos TL, Pereira-Carvalho R, Batista-Almeida D, Pereira R, Coelho-Santos V, Silva AP, Fernandes R, Zurarte M, Enguita FJ, Costa MC, Pinto-do-O P, Pinto M, Gouveia P, Ferreira L, Mason JC, Pereira P, Kwak BR, Nascimento DS, Girao H (2017) Exosomes secreted by cardiomyocytes subjected to ischaemia promote cardiac angiogenesis. Cardiovasc Res 113:1338\u20131350","journal-title":"Cardiovasc Res"},{"key":"2410_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/531740","author":"W Zhao","year":"2015","unstructured":"Zhao W, Zhao SP, Zhao YH (2015) MicroRNA-143\/-145 in cardiovascular diseases. BioMed Res Int. https:\/\/doi.org\/10.1155\/2015\/531740","journal-title":"BioMed Res Int"},{"key":"2410_CR30","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/ehf2.12354","volume":"5","author":"W Mohl","year":"2018","unstructured":"Mohl W, Spitzer E, Mader RM, Wagh V, Nguemo F, Milasinovic D, Jusic A, Khazen C, Szodorai E, Birkenberg B, Lubec G, Hescheler J, Serruys PW (2018) Acute molecular effects of pressure-controlled intermittent coronary sinus occlusion in patients with advanced heart failure. ESC Heart Fail 5:1176\u20131183","journal-title":"ESC Heart Fail"},{"key":"2410_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.amjcard.2012.02.054","volume":"110","author":"PK Bhat","year":"2012","unstructured":"Bhat PK, Ashwath ML, Rosenbaum DS, Costantini O (2012) Usefulness of left ventricular end-systolic dimension by echocardiography to predict reverse remodeling in patients with newly diagnosed severe left ventricular systolic dysfunction. Am J Cardiol 110:83\u201387","journal-title":"Am J Cardiol"},{"key":"2410_CR32","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1161\/CIRCHEARTFAILURE.110.958033","volume":"4","author":"AM Moilanen","year":"2011","unstructured":"Moilanen AM, Rysa J, Mustonen E, Serpi R, Aro J, Tokola H, Leskinen H, Manninen A, Levijoki J, Vuolteenaho O, Ruskoaho H (2011) Intramyocardial BNP gene delivery improves cardiac function through distinct context-dependent mechanisms. Circ Heart Fail 4:483\u2013495","journal-title":"Circ Heart Fail"},{"key":"2410_CR33","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJV McMurray","year":"2014","unstructured":"McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, PARADIGM-HF Investigators and Committees (2014) Angiotensin-Neprilysin inhibition versus Enalapril in heart failure. N Engl J Med 371:993\u20131004","journal-title":"N Engl J Med"},{"key":"2410_CR34","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.jacc.2019.01.018","volume":"73","author":"PL Myhre","year":"2019","unstructured":"Myhre PL, Vaduganathan M, Claggett B, Packer M, Desai AS, Rouleau JL, Zile MR, Swedberg K, Lefkowitz M, Shi V, McMurray JJV, Solomon SD (2019) B-type natriuretic peptide during treatment with sacubitril\/valsartan: The PARADIGM-HF Trial. J Am Coll Cardiol 73:1264\u20131272","journal-title":"J Am Coll Cardiol"},{"key":"2410_CR35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/ncb2441","volume":"14","author":"E Hergenreider","year":"2012","unstructured":"Hergenreider E, Heydt S, Treguer K, Boettger T, Horrevoets AJG, Zeiher AM, Scheffer MP, Frangakis AS, Yin X, Mayr M, Braun T, Urbich C, Boon RA, Dimmeler BS (2012) Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 14:249\u2013256","journal-title":"Nat Cell Biol"},{"key":"2410_CR36","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.amjsurg.2005.10.033","volume":"191","author":"M Kia","year":"2006","unstructured":"Kia M, Cooley A, Rimmer G, MacDonald T, Barber K, Manion P, Shapiro B, Socey J, Iddings D (2006) The efficacy of B-type natriuretic peptide for early identification of blood loss in traumatic injury. Am J Surg 191:353\u2013357","journal-title":"Am J Surg"},{"key":"2410_CR37","doi-asserted-by":"publisher","first-page":"7055","DOI":"10.1038\/s41598-018-25489-3","volume":"8","author":"J Wang","year":"2018","unstructured":"Wang J, Tong KS, Wong LL, Liew OW, Raghuram D, Richards AM, Chen YT (2018) MicroRNA-143 modulates the expression of natriuretic peptide receptor 3 in cardiac cells. Sci Rep 8:7055","journal-title":"Sci Rep"},{"key":"2410_CR38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1042\/BJ20070629","volume":"409","author":"A Weidemann","year":"2008","unstructured":"Weidemann A, Klanke B, Wagner M, Volk T, William C, Wiesener MS, Eckardt KU, Warnecke C (2008) Hypoxia, via stabilization of the hypoxia-inducible factor HIF-1 alpha, is a direct and sufficient stimulus for brain-type natriuretic peptide induction. Biochem J 409:233\u2013242","journal-title":"Biochem J"},{"key":"2410_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119742","volume":"280","author":"G Chen","year":"2021","unstructured":"Chen G, Wang M, Ruan Z, Zhu L, Tang C (2021) Mesenchymal stem cell-derived exosomal miR-143-3p suppresses myocardial ischemia-reperfusion injury by regulating autophagy. Life Sci 280:119742","journal-title":"Life Sci"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-024-02410-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00380-024-02410-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-024-02410-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T09:04:25Z","timestamp":1726477465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00380-024-02410-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,8]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["2410"],"URL":"https:\/\/doi.org\/10.1007\/s00380-024-02410-9","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,8]]},"assertion":[{"value":"10 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Gifu University Graduate School of Medicine (Approval number: 30-011) and Gifu Municipal Hospital (Approval number: 455).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB information"}}]}}